Therapeutic insulins and their large-scale manufacture
Author:
- 4 December 2004
- journal article
- review article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 67 (2) , 151-159
Abstract
Biotechnological innovations over the past 25 years have underpinned the rapid development of a thriving biopharmaceutical sector. Therapeutic insulin remains one of the most commonly used products of pharmaceutical biotechnology and insulin-based products command annual global sales in excess of $4.5 billion. Innovations in its method of production and in particular the advent of engineered insulin analogues provide a fascinating insight into how scientific and technological advances have impacted upon the pharmaceutical biotechnology sector as a whole. Current insulin-based diabetes research is increasingly focused not on the insulin molecule per se, but upon areas such as the development of non-parenteral insulin delivery systems, as well as organ-/cell-based and gene therapy-based approaches to controlling the disease.Keywords
This publication has 41 references indexed in Scilit:
- The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human InsulinPharmaceutical Research, 2004
- New Developments in Insulin DeliveryDrug Development and Industrial Pharmacy, 2003
- Oral insulin delivery1Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin.1Advanced Drug Delivery Reviews, 1999
- Insulin Lispro (Humalog)1999
- Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulinStructure, 1995
- Improving Insulin Therapy: Achievements and ChallengesHormone and Metabolic Research, 1994
- The History of InsulinDiabetes Care, 1993
- Research, Development, Production, and Safety of Biosynthetic Human InsulinDiabetes Care, 1993
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990
- Monomeric insulins obtained by protein engineering and their medical implicationsNature, 1988